BW-A868C

N/A

Report date: 2022/05/25 17:17:13

NME

Base Information

Drug NameBW-A868C

Drug Alias NameBW-A-868-CBW-A868C

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionProstaglandin D2 receptor antagonists

TargetsProstaglandin D2 receptor

Therapy Area/IndicationsThrombosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGlaxo Wellcome Inc

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsThrombosis

ATC CodeN/A